Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Implementation of proteomic biomarkers: making it work

Open access
Mischak, Harald, Ioannidis, John P.A., Argiles, Angel, Attwood, Teresa K., Bongcam‐Rudloff, Erik, Broenstrup, Mark, Charonis, Aristidis, Chrousos, George P, Delles, Christian, Dominiczak, Anna, Dylag, Tomasz, Ehrich, Jochen, Egido, Jesus, Findeisen, Peter, Jankowski, Joachim, Johnson, Robert W., Julien, Bruce A., Lankisch, Tim, Leung, Hing Y., Maahs, David, Magni, Fulvio, Manns, Michael P., Manolis, Efthymios, Mayer, Gert, Navis, Gerjan, Novak, Jan, Ortiz, Alberto, Persson, Frederik, Peter, Karlheinz, Riese, Hans H., Rossing, Peter, Sattar, Naveed, Spasovski, Goce, Thongboonkerd, Visith, Vanholder, Raymond, Schanstra, Joost P., Vlahou, Antonia·2012·European Journal of Clinical Investigation

Abstract

Eur J Clin Invest 2012; 42 (9): 1027–1036 While large numbers of proteomic biomarkers have been described, they are generally not implemented in medical practice. We have investigated the reasons for this shortcoming, focusing on hurdles downstream of biomarker verification, and describe major obstacles and possible solutions to ease valid biomarker implementation. Some of the problems lie in suboptimal biomarker discovery and validation, especially lack of validated platforms with well‐described performance characteristics to support biomarker qualification. These issues have been acknowledged and are being addressed, raising the hope that valid biomarkers may start accumulating in the foreseeable future. However, successful biomarker discovery and qualification alone does not suffice for successful implementation. Additional challenges include, among others, limited access to appropriate specimens and insufficient funding, the need to validate new biomarker utility in interventional trials, and large communication gaps between the parties involved in implementation. To address this problem, we propose an implementation roadmap. The implementation effort needs to involve a wide variety of stakeholders (clinicians, statisticians, health economists, and representatives of patient groups, health insurance, pharmaceutical companies, biobanks, and regulatory agencies). Knowledgeable panels with adequate representation of all these stakeholders may facilitate biomarker evaluation and guide implementation for the specific context of use. This approach may avoid unwarranted delays or failure to implement potentially useful biomarkers, and may expedite meaningful contributions of the biomarker community to healthcare.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2362.2012.02674.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 169

Metadata

Authors
Mischak, H., Ioannidis, J. P. A., Argiles, A., Attwood, T. K., Bongcam‐Rudloff, E., Broenstrup, M., Charonis, A., Chrousos, G. P., Delles, C., Dominiczak, A., Dylag, T., Ehrich, J., Egido, J., Findeisen, P., Jankowski, J., Johnson, R. W., Julien, B. A., Lankisch, T., Leung, H. Y., Maahs, D., Magni, F., Manns, M. P., Manolis, E., Mayer, G., Navis, G., Novak, J., Ortiz, A., Persson, F., Peter, K., Riese, H. H., Rossing, P., Sattar, N., Spasovski, G., Thongboonkerd, V., Vanholder, R., Schanstra, J. P., & Vlahou, A.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2012-04-21
Volume
42
Issue
9
Pages
1027-1036
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2125770956
Cited by
169
References
6
FWCI
8.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implementation of proteomic biomarkers: making it work. https://app.cochat.ai/papers/10.1111/j.1365-2362.2012.02674.x
The paper
Mischak, H., Ioannidis, J. P. A., Argiles, A., Attwood, T. K., Bongcam‐Rudloff, E., Broenstrup, M., Charonis, A., Chrousos, G. P., Delles, C., Dominiczak, A., Dylag, T., Ehrich, J., Egido, J., Findeisen, P., Jankowski, J., Johnson, R. W., Julien, B. A., Lankisch, T., Leung, H. Y., . . . Vlahou, A. (2012). Implementation of proteomic biomarkers: making it work. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2012.02674.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.